"The global electric vehicle market at $39.8 billion in

New Post Public Reply Private Reply Replies (0) Message Board
Goreman
97
"The global electric vehicle market at $39.8 billion in 2018 is projected to reach $1.5 trillion by 2025. Units sales are anticipated to reach 97 million vehicles worldwide by 2025. - Wintergreen Research Inc.


Ideanomics Reported Q2 Revenue of $4.7 million and Forecasts Quarter-over-Quarter EV Sales Growth in Q3 and Q4 2020


September 2020 - There are many investment opportunities for investors who want to capitalize on the growing EV industry. Leading the way is Tesla (Nasdaq-TSLA) who has seen tremendous amount of market attention and share appreciation in 2020. One company that is doing creative business in the EV sector is Ideanomics Inc. (Nasdaq-IDEX).

Ideanomics current focus is on commercial electric vehicle acquisitions and assisting commercial fleet operators with transitioning from their gas & diesel fleets through a procurement, lease financing, insurance, government rebates and subsidies, battery purchases and prepaid energy supply process and therefore providing “End to End” EV services.

Ideanomics names their platform “Sales to Financing to Charging” (S2F2C) business model.

Commercial fleet vehicles include heavy- duty trucks, logistic vehicles, buses, taxis, couriers, and the like.

China currently has an estimated 11 million heavy- duty trucks and off-road vehicles, 14 million delivery vehicles, 1.6 million city and tourist buses, 1.2 million taxis/ride-sharing vehicles, and more than 100,000 gas stations which are going to be converted into battery charging stations.

Ideanomics is doing business with these Chinese commercial fleet operators and is providing EV acquisitions, wholesale and pre-paid electricity or discounted access to Ideanomics’ preferred partner charging stations, which will be a recurring revenue stream for the Company.

Ideanomics established a new division named the Medici Motor Works to manufacture and sell EV Trucks, Vans & Bus into North America and other parts of the world.

To operate successfully in China Ideanomics has Chinese American entrepreneur billionaire Dr. Bruno Wu, who is the Chairman of Ideanomics who owns a 19% equity stake in the Company. Dr. Bruno Wu’s wife, Yang Lan, is a high-profile Chinese media personality who is often referred to as the Oprah Winfrey of China.

Vice Chairman Mr. Shane McMahon owns 4% and is from the multi billionaire American McMahon family which owns World Wresting Entertainment. (WWE)

Ideanomics recently reported Q2 revenue of $4.7 million, up from $378,000 in Q1. The Company ended the quarter with reducing its debt by ~ 50% and US$36.4 million in cash, which it says could be used for acquisitions later this year. IDEX called the second quarter its best mobile energy results since moving into electric vehicle sales. Further, Ideanomics forecasts quarter-over-quarter growth in Q3 and Q4 2020.

Another important component of IDEX’s future growth will come from its 51% majority ownership of Treeletrik, an approved electric vehicles manufacturer and distributor for Malaysia. As Treeletrik expands its product line to electric vehicle E bikes, mopeds, cars, and light rail cars and serving the 650 million people in the ASEAN region which includes Malaysia, Cambodia, Vietnam, Philippines, Indonesia, Laos, Singapore, and Brunei.

As the global EV sector continues its current growth trajectory with China being the largest EV market in the world, making up 57% of the global market as of April 2020; along with a market cap of $250 M and strong institutional and fund ownership with shareholders like BlackRock, Vanguard, State Street, Charles Schwab, Barclay's, and Fidelity, Ideanomics is well positioned to take advantage of this growth and capitalize on the EV market and provide investors with an opportunity for significant ROI.


Ideanomics Inc. (Nasdaq-IDEX) End to End EV Solutions


Revenue of $4.7 million Q2 and Expects Quarter-Over-Quarter Growth in Q3 and Q4 2020



557 EV Units Processed at MEG EV Center in Qingdao for July & August an Increase from Q 2


China is already the largest EV market in the world, making up 57% of the global market as of April 2020.


Ideanomics reported $4.7M Q2 in revenues in August. Most of the performance and growth of the company was brought about by the EV sales business of MEG, a Chinese subsidiary of Ideanomics.


Proactive Investor CEO Interview

Sept 17, 2020


https://www.youtube.com/watch?v=NVsrMFo4uec


Ideanomics Revenue Streams


Commercial EV Sales

Lease Financing – Sales

Qingdao EV Hub Sales

Medici Motor Works Trucks, Vans & Bus Sales

Treeletrik E Bike Sales




Energy Sales

Prepaid Electricity Commercial Fleet Sales

EV Fast Charging Network Sales

5G Smart City Energy Sales

Electricity Debit Card Sales (with China’s Union Pay)




Share Structure August 4, 2020


Market Cap $389,177,181

Outstanding Shares 237,303,159

Restricted Shares 73,424,144

Unrestricted Shares 163,531,862

52 Week Hi-lo $3.98-$0.27


Major Institutional Ownership: BlackRock, Vanguard, State Street, Charles Schwab, Barclay's, Fidelity


Symbol: IDEX: Nasdaq

www.ideanomics.com
Scroll down for more posts ▼

Top 10 Most Recent News Articles

2026 Community Impact Week: Slam Dunk for Community Unity

Updated Category News Views 2

Alright, if you're looking for a story that gives you those warm fuzzy feelings while wrapping you in a big sports hug, here it is. Imagine this: you've got basketball legends, world-class athletes, and a corporate heavyweight, all huddling up to make a community impact that's more than just warm air. Hoops, Hope, and High Fives The NBA Cares x Sands Cares Community...

Continue Reading
AbbVie's SKYRIZI and RINVOQ Highlight IBD Control Advances

Updated Category News Views 1

A Deeper Look Into AbbVie's Latest Data Let's cut straight to the science, folks. At the recent American College of Gastroenterology 2026 Annual Scientific Meeting, AbbVie pulled the curtain on 22 fresh scientific abstracts that are really shaking things up in the field of inflammatory bowel disease (IBD) treatment. Data from the Phase 3 AFFIRM study shined especially...

Continue Reading
Celltrion Unveils New Data on Infliximab: ACG 2026 Insight

Updated Category News Views 1

First Impressions: Celltrion's Latest Revelation Alright, let's jump straight into it. Celltrion USA is flaunting its latest findings on ZYMFENTRA® (infliximab-dyyb) for Crohn's disease and ulcerative colitis right at the American College of Gastroenterology's (ACG) grand event in 2026. If you've been watching the healthcare sector, this is significant news. It's got all...

Continue Reading
Duolingo Faces Lawsuit Over Alleged Investor Missteps

Updated Category News Views 5

Fasten your seatbelts, folks. We're diving into a legal tussle that could shake things up for Duolingo, Inc. (NASDAQ: DUOL). Investors who plunged into Duolingo shares between May 2, 2025, and February 26, 2026, might be feeling the heat now. They ought to brace for a class-action lawsuit frenzy with fingers pointed at Duolingo for allegedly pulling wool over investors'...

Continue Reading
Pacira BioSciences Faces Shareholder Revolt in M&A Deal

Updated Category News Views 1

A New Storm Brews Over Pacira's Sale to Viatris They say where there's smoke, there's fire, and it looks like Pacira BioSciences, Inc. (NASDAQ: PCRX) is running right into a bonfire thanks to their upcoming sale to Viatris Inc. On the face of it, shareholders are looking at a tidy $36.50 in cash per share, but not everyone's buying the deal as fair. Enter lawman Juan...

Continue Reading
NARUTO Card Game Set for June 2027 Global Launch

Updated Category News Views 7

Mark Your Calendars: Global Launch June 2027 They're rolling out a red carpet for nostalgia here, I tell ya! At the New York Comic Con, BANDAI announced a worldwide launch for the NARUTO CARD GAME in June 2027. We'll see pre-built decks starring your favorite shinobi and a mad sprint to collect with the new booster packs. Feels sort of like they’re summoning a jutsu...

Continue Reading
AI Drives Major Time Savings in Endoscopy Tech

Updated Category News Views 8

AI in Endoscopy: Game-Changer or Gimmick? Stumbling across AnX Robotica's latest pitch about their NaviCam ProScan AI workflow, one can't help but feel a mix of curiosity and skepticism. With the stakes in medical tech sky-high, they've fired off some impressive stats that grab attention. We're talking about cutting small-bowel capsule review times by a whopping...

Continue Reading
Sebela Pharma's Tegoprazan Posts Strong Phase 3 Data

Updated Category News Views 3

Spotlight on Tegoprazan: A New Player on the GERD Field Sometimes, a pharma company turns heads with data that speaks for itself. This time, Sebela Pharmaceuticals is doing just that with Tegoprazan's phase 3 results, shining a light on an area overlooked for too long: non-erosive reflux disease (NERD). Showing promise in its latest trials, Tegoprazan is muscling into the...

Continue Reading
LEGO Mashes Star Wars and Marvel for Fans' Delight

Updated Category News Views 2

A New Chapter in LEGO's Story Well, well, what do we have here? LEGO's throwing down the gauntlet. For the first time, they're asking fans to merge two colossal universes: Star Wars and Marvel. Talk about a brains-and-bricks bonanza! Announced at New York Comic Con with some star power from Kevin Smith, this LEGO Ideas challenge opens doors for fan creativity that might...

Continue Reading
Southern Company Sparks Swift Power Restoration Post-Isaias

Updated Category News Views 10

Well, when Mother Nature decides to throw a tantrum, it takes seasoned hands and savvy tech to clean up the mess. That's exactly what Southern Company is doing after Hurricane Isaias wreaked havoc on the Southeast. With their electric utilities—Alabama Power, Georgia Power, and Mississippi Power—hitting the ground running, they've already restored power to a whopping...

Continue Reading

Top 5 Most Recently Viewed Articles

Acumen Pharmaceuticals to Showcase Innovations at Conference

Updated Category News Views 115

Acumen Pharmaceuticals to Present at Health Conference Acumen Pharmaceuticals, Inc. (NASDAQ: ABOS), a pioneering clinical-stage biopharmaceutical company, is set to engage in a significant fireside chat at the 7th Annual Evercore ISI HealthCONx Conference. This event will happen shortly, providing a platform for Acumen to discuss their innovative approaches to tackling...

Continue Reading
Chanson International Holding Reports Fiscal Year 2025 Mid-Year Results

Updated Category News Views 192

Chanson International Holding Reports Mid-Year Financial Results Chanson International Holding (NASDAQ: CHSN) has recently unveiled its financial performance for the first half of the fiscal year 2025. As a key player in the bakery and beverage sectors, the company's unaudited results signify its resilience in a fluctuating market. Overview of Financial Performance...

Continue Reading
Investors Are Strategically Analyzing REGN Options Activity

Updated Category News Views 66

Examining Recent Changes in REGN Options There's been a noteworthy shift in sentiment among financial experts regarding Regeneron Pharmaceuticals. A recent analysis of the trading patterns in REGN options has revealed a blend of bullish and bearish movements in the market. This information serves as a foundation for understanding the current factors that are shaping...

Continue Reading
Analysts Raise Price Targets for CVS After Strong Earning Report

Updated Category News Views 99

CVS Health Exceeds Expectations with Recent Earnings CVS Health Corp (NYSE: CVS) delivered an impressive earnings report for its fourth quarter, showing robust sales numbers that surpassed analysts' expectations. The company announced fourth-quarter sales totaling an incredible $97.71 billion, outpacing the consensus estimate of $97.19 billion. Adjusted Earnings Report...

Continue Reading
Healthcare Triangle and Teyame AI Join Forces to Innovate Patient Engagement

Updated Category News Views 161

Healthcare Triangle Announces Strategic Partnership with Teyame AI Healthcare Triangle, Inc. (Nasdaq: HCTI) is excited to share its recent agreement with Teyame AI LLC, a visionary corporation aiming to revolutionize customer experience through artificial intelligence. This partnership is a transformative step that will not only enhance HCTI's SaaS capabilities but is...

Continue Reading